Leukemia & LymphomaSaunders, F.K., Winfield, D.A., Goeppel, J.R., Hancock, B.W., Sharrard, R.M. and Goyns, M.H. 2D-gel analysis of protein synthesis profiles of different stages of chronic lymphocytic leukemia. Leuk. Lymph. 14 (1994) 319L 322....
Chronic lymphocytic leukemia (CLL)can rarely be cured. Still, most people live with the disease for many years. Some people with CLL can live for years without treatment, but over time, most will need to be treated. Are there any survivors of leukemia? A leukemia survivor issomeone who has...
Serum beta(2)-microglobulin and serum thymidine kinase are independent predictors of progression-free survival in chronic lymphocytic leukemia and immunocy... Chronic lymphocytic leukemia (CLL) and immunocytoma (IC) are remarkably heterogeneous with regard to their clinical course. The current staging ...
(1990), Differential expression of LFA-1 alpha molecule in clinical stages of chronic B-lymphocytic leukemia patients. European Journal of Haematology, 45: 234–235. doi: 10.1111/j.1600-0609.1990.tb00463.x Author Information *Department of Microbiology-Immunology General Hospital Pordenone Italy ...
To determine whether c-myc is differently expressed at the various stages of the differentiation pathway, we used B-type chronic lymphocytic leukemia (B-CLL) cells, representing resting B lymphocytes, inducible to proliferation and/or differentiation in vitro. The c-myc protein, and Igλ-light ...
Therapy program for patients with advanced stages of chronic lymphocytic leukemia. Chlorambucil, splenectomy, and total lymph node irradiation. Cancer 1995; 75: 2853±61.Pegourie-Bandelier B, Sotto JJ, Hollard D, Bolla M, Sarrazin R (1995) Therapy program for patients with advanced stages of...
In chronic lymphocytic leukemia (CLL), the clinical stage has correlated with overall survival. We found that within the partial response (PR) category, changes in Binet clinical stage discriminated patients with different outcomes: those with PR-Binet A had better outcomes compared with those with...
BACKGROUND: Chronic lymphocytic leukemia (CLL) is a monoclonal disorder characterized by relentless accumulation of monoclonal B-cell. Beta-2 microglobulin (beta 2m) is an extracellular protein that is bound to the chain of Class 1 major histocompatibility complex molecule, which is present on all ...
The expression of the surface molecule CD38 on B cell chronic lymphocytic leukemia (B-CLL) cells has recently been described as a prognostic marker for patient survival. We have analyzed CD19/CD38 expression in 81 patients with predominantly early stages of B-CLL (69 Binet A, seven Binet B,...
Lymphocytic Leukemia: Clinical Stages Maintain Their Prognostic Significance Over the Course of the Disease and are Surrogates for Response to TherapyBinet clinical stageCLLDownstagingHeterogeneous outcomeResponse assessmentTo determine whether in patients with CLL clinical stages maintain their prognostic ...